Evaluation of a Large, Population-Based Sample Supports a CpG Island Methylator Phenotype in Colon Cancer
Wade S. Samowitz, Hans Albertsen, Jennifer S. Herrick et al. · Gastroenterology · 2005
Cited by 577 works. doi:10.1053/j.gastro.2005.06.020 Open-access PDF
Authors
- Wade S. Samowitz
- Hans Albertsen
- Jennifer S. Herrick
- Theodore R. Levin
- Carol Sweeney
- Maureen A. Murtaugh
- Roger K. Wolff
- Martha L. Slattery
References
- AJCC Cancer Staging Manual
- Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
- CpG island methylator phenotype in colorectal cancer
- RAF/RAS oncogenes and mismatch-repair status
- BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines.
- BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum
- Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype
- Energy balance and colon cancer--beyond physical activity.
- CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability
- Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level.